Koers Kaneh Bosm Biotechnology Inc Canadian Securities Exchange
Aandelen
CA4841902022
Drugshandelaren
Omzet 2018 | - | Omzet 2019 | - | Marktkapitalisatie | 13,23 mln. 18,14 mln. 12,34 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | - 0 0 | Nettowinst (verlies) 2019 | -60 mln. -82,26 mln. -55,97 mln. | EV/omzet 2018 * | - |
Nettoliquiditeiten 2018 * | - 0 0 | Nettoliquiditeiten 2019 * | - 0 0 | EV/omzet 2019 * | - |
K/w-verhouding 2018 * |
-
| K/w-verhouding 2019 * |
-
| Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 * |
-
| Vrij verhandelbaar | 0% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Shpilt
CEO | Chief Executive Officer | - | 15-04-19 |
Eugene Beukman
BRD | Director/Board Member | 64 | 27-04-18 |
Corporate Officer/Principal | - | 25-04-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eugene Beukman
BRD | Director/Board Member | 64 | 27-04-18 |
Matthew Fish
BRD | Director/Board Member | - | 29-05-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,40% | 2,76 mld. | |
-21,77% | 1,16 mld. | |
+47,99% | 503 mln. | |
-12,27% | 411 mln. | |
+61,50% | 202 mln. | |
-1,11% | 95,1 mln. | |
+41,57% | 57,08 mln. |